Palliative Care Approaches in Machado-Joseph Disease

被引:0
作者
Arruda, Mara [1 ]
Vidal, Carolina [2 ]
Serpa, Maria Joao [2 ]
Goncalves, Antonio [2 ]
Vidal, Rosario [2 ]
机构
[1] Ctr Saude Praia da Vitoria, Unidade Saude Ilha Terceira, Rua Artesia, P-9760586 Praia Da Vitoria, Portugal
[2] Hosp Divino Espirito Santo Ponta Delgada, Unidade Cuidados Paliat, Ponta Delgada, Portugal
关键词
Machado-Joseph disease; palliative care; spinocerebellar ataxia;
D O I
10.1089/jpm.2024.0468
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Spinocerebellar ataxias (SCA) are a rare group of neurodegenerative disorders. Machado-Joseph disease (MJD) is the most prevalent autosomal dominant ataxia. No disease-modifying treatment exists; thus, a palliative approach is recommended upon diagnosis.Objective: The objective of this study is to describe the first cohort of MJD patients followed by a palliative care team. We aimed to describe the main symptoms experienced by patients with advanced MJD and detail the multidisciplinary approaches employed to enhance their quality of life.Methods: We retrospectively analyzed patients with SCA referred to the palliative care unit (PCU) at Hospital do Divino Esp & iacute;rito Santo de Ponta Delgada. Data collected from June 1, 2016, to February 29, 2024, included demographic characteristics, functional status, Edmonton Symptom Assessment Scale scores, medication use, alternative feeding methods, advanced care planning documentation, interdisciplinary interventions, and hospital admissions. Statistical analysis was performed using nonparametric tests.Results: The median follow-up duration was five years, and the median disease duration was 18.5 years. Swallowing difficulties, constipation, depression, and insomnia were the most frequent symptoms. Insomnia was statistically more prevalent among the MJD group. The mortality rate was 30%, and 55% of deaths were related to disease progression. The deceased group had a longer disease duration and follow-up than the survival group.Conclusions: To the best of our knowledge, this is the first cohort description of MJD patients followed by a PCU. We found that swallowing difficulties, constipation, depression, and insomnia were the most frequent symptoms. In addition to pharmacological treatment, interdisciplinary approaches played a central role in addressing the needs of this cohort of patients with advanced MJD.
引用
收藏
页数:9
相关论文
共 24 条
  • [1] Opal P, Zoghbi HY, Overview of the hereditary ataxias, UpToDate, pp. 1-21, (2016)
  • [2] Opal P, Zoghbi HY, Autosomal dominant spinocerebellar ataxias: The subtypes, UpToDate, 68, 1, pp. 92-93, (2020)
  • [3] Rezende TJR, de Paiva JLR, Martinez ARM, Et al., Structural signature of SCA3: From presymptomatic to late disease stages, Ann Neurol, 84, 3, pp. 401-408, (2018)
  • [4] Lima M, Raposo M, Ferreira A, Et al., The homogeneous Azorean Machado-Joseph disease cohort: Characterization and contributions to advances in research, Biomedicines, 11, 2, (2023)
  • [5] Jardim LB, Pereira ML, Silveira I, Et al., Neurologic findings in Machado-Joseph disease, Arch Neurol, 58, 6, pp. 899-904, (2001)
  • [6] Paulson H, Machado-Joseph disease/spinocerebellar ataxia type 3, Handb Clin Neurol, 103, pp. 437-449, (2012)
  • [7] Todd P, Sakkottai VG, Overview of cerebellar ataxia in adults, UpToDate, pp. 1-52, (2019)
  • [8] D'Abreu A, Franca MC, Paulson HL, Lopes-Cendes I, Caring for Machado-Joseph disease: Current understanding and how to help patients, Parkinsonism Relat Disord, 16, 1, pp. 2-7, (2010)
  • [9] Pedroso JL, Franca MC, Braga-Neto P, Et al., Nonmotor and extracerebellar features in Machado-Joseph disease: A review, Mov Disord, 28, 9, pp. 1200-1208, (2013)
  • [10] Cecchin CR, Pires AP, Rieder CR, Et al., Depressive symptoms in Machado-Joseph Disease (SCA3) patients and their relatives, Community Genet, 10, 1, pp. 19-26, (2007)